ロード中...
Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age
OBJECTIVE: To evaluate the safety and efficacy of intravenous golimumab + methotrexate (MTX) in patients with active rheumatoid arthritis (RA) aged < 65 years and those ≥ 65 years who were enrolled in the GO-FURTHER study. METHODS: In the phase III, double-blind, randomized, placebo-controlled GO...
保存先:
| 出版年: | Arthritis Res Ther |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6701065/ https://ncbi.nlm.nih.gov/pubmed/31429794 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-019-1968-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|